ML 315

• Description:

  ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  374.22

• Molecular Formula:

  C18H13Cl2N3O2

• Notes:

  Research use only, not for human use.

• Receptor:

  DYRK | CDK

• CAS Number:

  1440251-53-5